Go Pro
OTCMKTS:BFNH

BioForce Nanosciences Q2 2026 Earnings Report

BioForce Nanosciences logo
$9.25 -0.13 (-1.42%)
As of 09/21/2026 03:59 PM Eastern

BioForce Nanosciences EPS Results

Actual EPS
$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

BioForce Nanosciences Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

BioForce Nanosciences Announcement Details

Quarter
Q2 2026
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

BioForce Nanosciences Earnings Headlines

BioForce Nanosciences Delays Annual 10-K Filing
Arizona Gold Explorer Nears First-Ever Resource Estimate
A little-known Arizona gold explorer just hit 66.2 metres grading 6.57 g/t gold, including 20.7 metres at 18.25 g/t. After roughly 21,000 metres of drilling, the company is closing in on its first-ever mineral resource estimate, expected in Q3 or Q4 2026. That estimate could offer the market its first real look at the scale of this emerging gold system.tc pixel
See More BioForce Nanosciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BioForce Nanosciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioForce Nanosciences and other key companies, straight to your email.

About BioForce Nanosciences

BioForce Nanosciences (OTCMKTS:BFNH) is a nanotechnology company that developed instrumentation, consumables and related technologies for life sciences research and nanoscale surface engineering. Its products were designed to help researchers manipulate very small volumes of liquids and create controlled patterns of biological or chemical materials on surfaces.

The company’s best-known technology was the Nano eNabler platform, also described as a molecular printer. The system used specialized dispensing tools to deposit precise quantities of fluids, enabling applications such as biomolecular patterning, microarray fabrication, cell-based research and other laboratory experiments involving nanoscale structures.

BioForce Nanosciences served research institutions, biotechnology companies and other organizations working in nanotechnology and the life sciences. Publicly available information about the company’s current operations, geographic reach and leadership is limited, and its present business status is unclear.

View BioForce Nanosciences Profile